The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages
Open accessAbstract
Pulmonary metastasis of breast cancer cells is promoted by a distinct population of macrophages, metastasis-associated macrophages (MAMs), which originate from inflammatory monocytes (IMs) recruited by the CC-chemokine ligand 2 (CCL2). We demonstrate here that, through activation of the CCL2 receptor CCR2, the recruited MAMs secrete another chemokine ligand CCL3. Genetic deletion of CCL3 or its receptor CCR1 in macrophages reduces the number of lung metastasis foci, as well as the number of MAMs accumulated in tumor-challenged lung in mice. Adoptive transfer of WT IMs increases the reduced number of lung metastasis foci in Ccl3 deficient mice. Mechanistically, Ccr1 deficiency prevents MAM retention in the lung by reducing MAM–cancer cell interactions. These findings collectively indicate that the CCL2-triggered chemokine cascade in macrophages promotes metastatic seeding of breast cancer cells thereby amplifying the pathology already extant in the system. These data suggest that inhibition of CCR1, the distal part of this signaling relay, may have a therapeutic impact in metastatic disease with lower toxicity than blocking upstream targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
Self-citationAccessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632
Microenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684 · cited 1×
“A newly appreciated target for therapy is the tumor microenvironment (Joyce and Pollard, 2009; recruitment of prometastatic CD11b+ MAMs is reduced by lack of stromal CCL2 or CCL3 in breast cancer models (Fig.”
BackgroundSelf-citationGenes that mediate breast cancer metastasis to lung
Minn, A. J., Gupta, G. P., Siegel, P. M., Bos, P. D., Shu, W., Giri, D. D., Viale, A., Olshen, A. B., Gerald, W. L., & Massagué, J. (2005) · Nature · doi:10.1038/nature03799 · Cited by 2,922
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
Qian, B.-Z., Li, J., Zhang, H., Kitamura, T., Zhang, J., Campion, L. R., Kaiser, E. A., Snyder, L. A., & Pollard, J. W. (2011) · Nature · doi:10.1038/nature10138 · Cited by 2,874
Self-citationDavies, L. C., Jenkins, S. J., Allen, J. E., & Taylor, P. R. (2013) · Nature Immunology · doi:10.1038/ni.2705 · Cited by 2,096
Bingle, L., Brown, N. J., & Lewis, C. E. (2002) · The Journal of Pathology · doi:10.1002/path.1027 · Cited by 2,022
Stromal gene expression predicts clinical outcome in breast cancer
Finak, G., Bertos, N., Pepin, F., Sadekova, S., Souleimanova, M., Zhao, H., Chen, H., Omeroglu, G., Meterissian, S., Omeroglu, A., et al. (2008) · Nature Medicine · doi:10.1038/nm1764 · Cited by 1,687
Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy
Lin, E. Y., Nguyen, A. V., Russell, R. G., & Pollard, J. W. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.6.727 · Cited by 1,594
Self-citationThe cellular and molecular origin of tumor-associated macrophages
Franklin, R. A., Liao, W., Sarkar, A., Kim, M. V., Bivona, M. R., Liu, K., Pamer, E. G., & Li, M. O. (2014) · Science · doi:10.1126/science.1252510 · Cited by 1,393
Alveolar macrophages: plasticity in a tissue-specific context
Hussell, T., & Bell, T. J. (2014) · Nature Reviews Immunology · doi:10.1038/nri3600 · Cited by 1,377
Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma.
Leek, R., Lewis, C. E., Whitehouse, R. M., Greenall, M. J., Clarke, J., & Harris, A. L. (1996) · PubMed · Cited by 1,187
Trophic macrophages in development and disease
Pollard, J. W. (2009) · Nature Reviews Immunology · doi:10.1038/nri2528 · Cited by 1,178
Self-citationMonocyte-Mediated Defense Against Microbial Pathogens
Serbina, N. V., Jia, T., Hohl, T. M., & Pamer, E. G. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090326 · Cited by 1,123
Lin, E. Y., Jones, J. G., Li, P., Zhu, L., Whitney, K. D., Muller, W. J., & Pollard, J. W. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63568-7 · Cited by 1,107
Self-citationIdentification of molecular apocrine breast tumours by microarray analysis
Farmer, P., Bonnefoi, H., Becette, V., Tubiana-Hulin, M., Fumoleau, P., Larsimont, D., MacGrogan, G., Bergh, J., Cameron, D., Goldstein, D., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208561 · Cited by 785
Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor
Neote, K., DiGregorio, D., Mak, J. Y., Horuk, R., & Schall, T. J. (1993) · Cell · doi:10.1016/0092-8674(93)90118-a · Cited by 763
Matsushima, K., Larsen, C. G., DuBois, G. C., & Oppenheim, J. J. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.4.1485 · Cited by 756
Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis
Bonapace, L., Coissieux, M.-M., Wyckoff, J., Mertz, K. D., Varga, Z., Junt, T., & Bentires-Alj, M. (2014) · Nature · doi:10.1038/nature13862 · Cited by 665
Qian, B., Deng, Y., Im, J. H., Muschel, R. J., Zou, Y., Li, J., Lang, R. A., & Pollard, J. W. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006562 · Cited by 664
Self-citationTushinski, R. J., Oliver, I. T., Guilbert, L. J., Tynan, P. W., Warner, J. R., & Stanley, E. R. (1982) · Cell · doi:10.1016/0092-8674(82)90376-2 · Cited by 662
Chen, Q., Zhang, X. H.-F., & Massagué, J. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.08.025 · Cited by 619
Roca, H., Varsos, Z. S., Sud, S., Craig, M. J., Ying, C., & Pienta, K. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.042671 · Cited by 569
Overcoming hurdles in developing successful drugs targeting chemokine receptors
Schall, T. J., & Proudfoot, A. E. I. (2011) · Nature Reviews Immunology · doi:10.1038/nri2972 · Cited by 318
Identification of molecular apocrine breast tumours by microarray analysis
Farmer, P., Bonnefoi, H., Becette, V, Tubiana-Hulin, M., Fumoleau, P., Larsimont, D., MacGrogan, G., Bergh, J., Cameron, D., Goldstein, D., et al. (2005) · Breast Cancer Research · doi:10.1186/bcr1122 · Cited by 307
Sandhu, S. K., Papadopoulos, K., Fong, P. C., Patnaik, A., Messiou, C., Olmos, D., Wang, G., Tromp, B. J., Puchalski, T. A., Balkwill, F., et al. (2013) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-013-2099-8 · Cited by 272
Weber, C., Weber, K. S. C., Klier, C., Gu, S., Wank, R., Horuk, R., & Nelson, P. J. (2001) · Blood · doi:10.1182/blood.v97.4.1144 · Cited by 262
Lu, X., & Kang, Y. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.035899 · Cited by 257
High-Density Gene Expression Analysis of Tumor-Associated Macrophages from Mouse Mammary Tumors
Ojalvo, L. S., King, W., Cox, D., & Pollard, J. W. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080676 · Cited by 221
Self-citationLloyd, A. R., Oppenheim, J. J., Kelvin, D. J., & Taub, D. D. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.3.932 · Cited by 200
Borowsky, A. D., Namba, R., Young, L. J. T., Hunter, K. W., Hodgson, J. G., Tepper, C. G., McGoldrick, E. T., Muller, W. J., Cardiff, R. D., & Gregg, J. P. (2005) · Clinical & Experimental Metastasis · doi:10.1007/s10585-005-2908-5 · Cited by 194
Systemic delivery of neutralizing antibody targeting CCL2 for glioma therapy
Zhu, X., Fujita, M., Snyder, L. A., & Okada, H. (2011) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0473-5 · Cited by 189
Kitamura, T., Fujishita, T., Loetscher, P., Revesz, L., Hashida, H., Kizaka-Kondoh, S., Aoki, M., & Taketo, M. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002372107 · Cited by 178
Self-citationWu, Y., Li, Y.-Y., Matsushima, K., Baba, T., & Mukaida, N. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.9.6384 · Cited by 166
Ramos, C. D. L., Canetti, C., Souto, J. T., Silva, J. S., Hogaboam, C. M., Ferreira, S. H., & Cunha, F. Q. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0404237 · Cited by 160
Oba, Y., Lee, J., Ehrlich, L. A., Chung, H. Y., Jelinek, D. F., Callander, N. S., Horuk, R., Choi, S. J., & Roodman, G. D. (2005) · Experimental Hematology · doi:10.1016/j.exphem.2004.11.015 · Cited by 156
Distant metastasis from subcutaneously grown E0771 medullary breast adenocarcinoma.
Ewens, A. D., Mihich, E., & Ehrke, M. J. (2005) · PubMed · Cited by 150
Conditional deletion of the colony stimulating factor-1 receptor (c-fms proto-oncogene) in mice
Li, J., Chen, K., Zhu, L., & Pollard, J. W. (2006) · genesis · doi:10.1002/dvg.20219 · Cited by 133
Self-citationEis, V., Luckow, B., Vielhauer, V., Siveke, J. T., Linde, Y., Segerer, S., de Lema, G. P., Cohen, C. D., Kretzler, M., Mack, M., et al. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000111246.87175.32 · Cited by 133
Kaufmann, A. M., Salentin, R., Gemsa, D., & Sprenger, H. (2001) · PubMed · Cited by 126
CCL3 and CXCL12 regulate trafficking of mouse bone marrow NK cell subsets
Bernardini, G., Sciumè, G., Bosisio, D., Morrone, S., Sozzani, S., & Santoni, A. (2008) · Blood · doi:10.1182/blood-2007-08-106203 · Cited by 117
Kaufmann, A. M., Salentin, R., Gemsa, D., & Sprenger, H. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.69.2.248 · Cited by 112
Tak, P. P., Balanescu, A. R., Tseluyko, V., Bojin, S., Drescher, E., Dairaghi, D. J., Miao, S., Marchesin, V., Jaén, J. C., Schall, T. J., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-201605 · Cited by 100
Inflammation triggers emergency granulopoiesis through a density-dependent feedback mechanism
Cain, D. W., Snowden, P. B., Sempowski, G. D., & Kelsoe, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019957 · Cited by 95
CCR1 blockade reduces tumor burden and osteolysis in vivo in a mouse model of myeloma bone disease
Dairaghi, D. J., Oyajobi, B. O., Gupta, A., McCluskey, B., Miao, S., Powers, J. P., Seitz, L. C., Wang, Y., Zeng, Y., Zhang, P., et al. (2012) · Blood · doi:10.1182/blood-2011-10-384784 · Cited by 86
Macrophages and the hypoxic tumour microenvironment
Knowles, H. J. (2007) · Frontiers in bioscience · doi:10.2741/2389 · Cited by 77
RANTES-Induced Chemokine Cascade in Dendritic Cells
Fischer, F. R., Luo, Y., Luo, M., Santambrogio, L., & Dorf, M. E. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1637 · Cited by 74
Cassetta, L., Kajaste‐Rudnitski, A., Coradin, T., Saba, E., Chiara, G. D., Barbagallo, M., Graziano, F., Alfano, M., Cassol, E., Vicenzi, E., et al. (2013) · AIDS · doi:10.1097/qad.0b013e328361d059 · Cited by 68
Self-citationMacrophage Inflammatory Protein-2 and KC Induce Chemokine Production by Mouse Astrocytes
Luo, Y., Fischer, F. R., Hancock, W. W., & Dorf, M. E. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.7.4015 · Cited by 66
Nakasone, Y., Fujimoto, M., Matsushita, T., Hamaguchi, Y., Huu, D. L., Yanaba, M., Sato, S., Takehara, K., & Hasegawa, M. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.09.005 · Cited by 63
Dairaghi, D. J., Zhang, P., Wang, Y., Seitz, L. C., Johnson, D. A., Miao, S., Ertl, L. S., Zeng, Y., Powers, J. P., Pennell, A. M. K., et al. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.33 · Cited by 58
A Key Role for CC Chemokine Receptor 1 in T-Cell-Mediated Respiratory Inflammation
Schaller, M. A., Kallal, L. E., & Lukacs, N. W. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070537 · Cited by 45
Tanaka, T., Terada, M., Ariyoshi, K., & Morimoto, K. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.07.141 · Cited by 44
Iida, N., Nakamoto, Y., Baba, T., Kakinoki, K., Li, Y.-Y., Wu, Y., Matsushima, K., Kaneko, S., & Mukaida, N. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.1107791 · Cited by 44
Prest, S. J., Rees, R. C., Murdoch, C., et al. (1999) · Clinical & Experimental Metastasis · doi:10.1023/a:1006657109866 · Cited by 42
Rodero, M. P., Auvynet, C., Poupel, L., Combadière, B., & Combadière, C. (2013) · Neoplasia · doi:10.1593/neo.121866 · Cited by 33
Wang, M. J., Jeng, K. C. G., & Shih, P. C. (2000) · Cellular Immunology · doi:10.1006/cimm.2000.1697 · Cited by 19
Moog-Lutz (1997) · Pure Amsterdam UMC · doi:10.1002/(sici)1097-0215(19970410)71:2
Cited by
Understanding the tumor immune microenvironment (TIME) for effective therapy
Binnewies, M., Roberts, E. W., Kersten, K., Chan, V., Fearon, D. F., Merad, M., Coussens, L. M., Gabrilovich, D. I., Ostrand-Rosenberg, S., Hedrick, C. C., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0014-x · Cited by 6,145
Tumour-associated macrophages as treatment targets in oncology
Mantovani, A., Marchesi, F., Malesci, A., Laghi, L., & Allavena, P. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.217 · Cited by 4,033
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
Nagarsheth, N., Wicha, M. S., & Zou, W. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.49 · Cited by 2,206
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
Kumar, V., Patel, S., Tcyganov, E., & Gabrilovich, D. I. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.01.004 · Cited by 2,008
Targeting macrophages: therapeutic approaches in cancer
Cassetta, L., & Pollard, J. W. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.169 · Cited by 2,048
Self-citation
Metadata
- Authors
- Kitamura, T., Qian, B.-Z., Soong, D., Cassetta, L., Noy, R., Sugano, G., Kato, Y., Li, J., & Pollard, J. W.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2015-06-08
- Volume
- 212
- Issue
- 7
- Pages
- 1043-1059
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W1908116487
- Cited by
- 651
- References
- 59
- FWCI
- 23.22
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.